Concord Medical Services Holdings
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.28
- Today's High:
- $1.42
- Open Price:
- $1.42
- 52W Low:
- $1.03
- 52W High:
- $2.1
- Prev. Close:
- $1.33
- Volume:
- 607
Company Statistics
- Market Cap.:
- $57.74 million
- Book Value:
- -42.931
- Revenue TTM:
- $472.08 million
- Operating Margin TTM:
- -111.22%
- Gross Profit TTM:
- $-152409000
- Profit Margin:
- -103.72%
- Return on Assets TTM:
- -5.36%
- Return on Equity TTM:
- -32.31%
Company Profile
Concord Medical Services Holdings had its IPO on 2009-12-11 under the ticker symbol CCM.
The company operates in the Healthcare sector and Medical Care Facilities industry. Concord Medical Services Holdings has a staff strength of 918 employees.
Stock update
Shares of Concord Medical Services Holdings opened at $1.42 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.28 - $1.42, and closed at $1.29.
This is a -3.01% slip from the previous day's closing price.
A total volume of 607 shares were traded at the close of the day’s session.
In the last one week, shares of Concord Medical Services Holdings have slipped by -4.44%.
Concord Medical Services Holdings's Key Ratios
Concord Medical Services Holdings has a market cap of $57.74 million, indicating a price to book ratio of 3.0038 and a price to sales ratio of 0.1451.
In the last 12-months Concord Medical Services Holdings’s revenue was $472.08 million with a gross profit of $-152409000 and an EBITDA of $-401860992. The EBITDA ratio measures Concord Medical Services Holdings's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Concord Medical Services Holdings’s operating margin was -111.22% while its return on assets stood at -5.36% with a return of equity of -32.31%.
In Q1, Concord Medical Services Holdings’s quarterly earnings growth was a positive 0% while revenue growth was a positive 12%.
Concord Medical Services Holdings’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-1.55 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Concord Medical Services Holdings’s profitability.
Concord Medical Services Holdings stock is trading at a EV to sales ratio of 1.1381 and a EV to EBITDA ratio of -0.9793. Its price to sales ratio in the trailing 12-months stood at 0.1451.
Concord Medical Services Holdings stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0
- Total Liabilities
- $0
- Operating Cash Flow
- $0
- Capital Expenditure
- $397.40 million
- Dividend Payout Ratio
- 0%
Concord Medical Services Holdings ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.
Concord Medical Services Holdings ended 2024 with $0 in deferred long-term liabilities, $0 in other current liabilities, in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Concord Medical Services Holdings’s total current assets stands at $0 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.
In 2024, Concord Medical Services Holdings's operating cash flow was $0 while its capital expenditure stood at $397.40 million.
Comparatively, Concord Medical Services Holdings paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.29
- 52-Week High
- $2.1
- 52-Week Low
- $1.03
- Analyst Target Price
- $
Concord Medical Services Holdings stock is currently trading at $1.29 per share. It touched a 52-week high of $2.1 and a 52-week low of $2.1. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $1.35 and 200-day moving average was $1.38 The short ratio stood at 1.2 indicating a short percent outstanding of 0%.
Around 1799.5% of the company’s stock are held by insiders while 37.6% are held by institutions.
Frequently Asked Questions About Concord Medical Services Holdings
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company’s other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People’s Republic of China.